Volume 14, Issue 1 (January & February 2023)                   BCN 2023, 14(1): 137-142 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Khamseh F, Hadjati G, Nahvinejad H, Nouparast Z, Salehi M, Noroozian M, et al . Comparing the Diagnostic Value of Four Dementia Tests in the Amnestic and Healthy Elderly. BCN 2023; 14 (1) :137-142
URL: http://bcn.iums.ac.ir/article-1-1457-en.html
1- Iranian Association of Alzheimer’s Disease, Tehran, Iran.
2- Iranian State Welfare Organization, Tehran, Iran.
3- Department of Neurology, Tehran University of Medical Sciences, Tehran, Iran.
4- Iranian Research Center on Aging, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
5- Shafa Health Research Center, Tehran, Iran.
Introduction: This study aimed to compare the diagnostic value of four questionnaires for the diagnosis of neurocognitive disorders (NCDs) in the elderly.
Methods:  In this project, people older than 60 years who lived in Tehran were investigated. A total of 99 literate cases were enrolled in the study, and four questionnaires, including functional assessment staging tool (FAST), abbreviated mental test score (AMTS), mini-mental state examination (MMSE), and modified Persian test of elderly for assessment of cognition and executive function (PEACE) were completed for them. They were then referred to a neuropsychiatrist, and the status of their cognition and neurobehavior was determined. The specialists were blinded to the results of the tests.
Results: Of the 99 participants studied, 39 cases were healthy, eight cases had mild Alzheimer’s disease, 38 had amnesic MCI, five cases had secondary dementia, and nine cases had mixed vascular dementia and Alzheimer’s disease. The area under the ROC curve for distinguishing the healthy group from the rest of the population was 0.692, 0.629, 0.734, and 0.751 for the FAST, AMTS, MMSE, and NBCSS questionnaires, respectively.
Conclusion: MMSE and NBCSS tests had better diagnostic power than the other two tests to distinguish the healthy group from the rest of the population.

Type of Study: Original | Subject: Clinical Neuroscience
Received: 2019/03/16 | Accepted: 2020/11/7 | Published: 2023/01/1

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Basic and Clinical Neuroscience

Designed & Developed by : Yektaweb